- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07940972
Evaluation of Self-Assembling Peptides (Curodont Protect) in Managing Post Bleaching Hypersensitivity
Evaluation of Self-Assembling Peptides in Managing Post Bleaching Hypersensitivity
The goal of this clinical trial is to learn if using self assembling peptides reduce post operative bleaching hypersensitivity in middle aged patients (18-40).
Research will evaluate the efficacy of self-assembling peptide in reducing hypersensitivity after bleaching compared to Potassium Nitrate and Sodium Fluoride participants will all recive the same bleaching kit and protocol following the intruction provided by bleaching kit Will then be assorted into two groups which one will recive Potassium Nitrate and Sodium Fluoride and the other with recive self assembling peptide post bleaching Hypersensitivity will be evaluated immediately after the bleaching procedure , immediately after the application of the remineralizing/desensitizing agent , after 24 hours , and after one week
Study Overview
Status
Intervention / Treatment
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Ahmed Ezzat Kamel, bachelor degree
- Phone Number: +201091010062
- Email: Ahmed.ezzat1025@nub.edu.eg
Study Locations
-
-
Bayad Al Arab
-
Banī Suwayf, Bayad Al Arab, Egypt, 62764
- Recruiting
- Nahda university
-
Contact:
- shaymaa Mohamed Nagi, Professor
- Phone Number: +201223961781
- Email: shaimaa.mohamed@nub.edu.eg
-
Contact:
- Khaled Wagih Al-Saudi, Lecturer
- Email: khaled.wagih@nub.edu.eg
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18 and 40 years.
- All teeth that need bleaching are free from caries, filings or periodontal disease. - Low caries index.
- Patients with VITA- color teeth shade A2 or darker.
- Patients with cooperative behavior and medically free.
Exclusion Criteria:
- Patients with severe intrinsic discoloration.
- Patient with history of teeth hypersensitivity.
- Taking analgesics/anti-inflammatory drugs at the time of the study, pregnancy, and smoking.
- Any professional desensitizing therapy on the selected teeth during the last 6 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Power white After Whitening Mousse
|
Dispense a small amount and apply a thin layer of the After Whitening Mousse directly onto the surface of the teeth Allow the mousse to remain on the teeth for 10 to 15 minutes. The patient can often leave the dental practice with the mousse still applied |
|
Active Comparator: Curodont protect
|
Apply the gel over the entire dentition or targeted teeth using a microbrush. Leave the gel undisturbed for 1 to 2 minutes. The patient can spit out any excess residue, but do not rinse immediately with water to allow the active ingredients to maintain contact with the enamel. For sensitive teeth or professional cleanings/bleaching, apply 2 minutes before and after the procedure |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The Effect of Self Assembling Peptides on treatment of post bleaching hypersensitivity using Visual Analog scale for assessment
Time Frame: from bleaching day up to 7 days
|
from bleaching day up to 7 days
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Stomatognathic Diseases
- Tooth Diseases
- Dentin Sensitivity
- Cariostatic Agents
- Inorganic Chemicals
- Biomedical and Dental Materials
- Manufactured Materials
- Technology, Industry, and Agriculture
- Anions
- Ions
- Electrolytes
- Sodium Compounds
- Hydrofluoric Acid
- Fluorine Compounds
- Fluorides
- Sodium Fluoride
- potassium nitrate
Other Study ID Numbers
- 00-A-1-26-1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.